Abstract:O177* Purpose: It is established that transplant tolerance can be adoptively transferred from tolerant recipients to a naive recipient by T cells, a phenomena termed ,,infectious tolerance“. To date, the ability of other cells to transfer tolerance has not been demonstrated. The present study aims to determine whether tolerogenic dendritic cells (Tol-DC) isolated from tolerant mice can transfer graft-specific tolerance to naive recipients, and to dissect the mechanisms underlining infectious tolerance induced by Tol-DC. Methods: BALB/c mice receiving C57BL/6 cardiac allografts were treated with LF 15-0195, a novel analogue of 15-deoxyspergualine at a dose of 2 mg/kg for 20 days. Long-term survivors (>100 days) were defined as tolerant recipients. Tol-DC were isolated from tolerant recipients by anti-CD11c mAb-conjugated MACS beads. Tol-DC were intravenously injected into syngeneic (BALB/c) recipients followed by allogeneic (C57/BL6>Balb/c) heterotopic heart transplantation. Results: The Tol-DC isolated from tolerant recipients demonstrated an immature phenotype as exemplified by diminished expression of MHC II, CD40, and CD86. Functionally, Tol-DC failed to stimulate allogeneic T cell responses in MLR. Furthermore, the addition of Tol-DC isolated from tolerant recipients inhibited ongoing MLR, suggesting Tol-DC play a regulatory role. To further investigate the in vivo regulatory function of Tol-DC, ex vivo isolated Tol-DC (5x106 cells/mouse) from tolerant recipients were adoptively transferred into naive syngeneic recipients. While transferring control DC resulted no protection of allografts (MST 13 ± 1 day), transferring Tol-DC significantly prolonged allograft survival (MST 45 ± 8 days) in the absence of immune suppressants, suggesting an “infectious tolerance” occurred after adoptive transfer of Tol-DC. We next investigated whether transfer of Tol-DC was associated with generation of Treg. Indeed, subsequent to Tol-DC adoptive transfer, an increase in the CD4+CD25+ Treg subset was observed. Furthermore, CD4+CD25+CTLA4+ cells were detected at 31% after Tol-DC transfer compared to 6.1% in controls. Functionally, these Treg inhibited ongoing MLR in vitro. Finally, we examined the expression of indolamine-2,3-deoxygenase (IDO), an novel DC-derived T cell inhibiting enzyme, was remarkably up-regulated in the spleens of recipients after adoptive transfer of Tol-DC but not control DC. Conclusions: This study is the first demonstration of infectious tolerance by DC. The transplant tolerance can be adoptively transferred from a tolerant recipients to a naïve mouse. Mechanisms involved include generation of Treg in vivo and upregulation of IDO.

SYNERGISTIC TOLERANCE BY ADOPTIVE TRANSFER OF TOLEROGENIC DENDRITIC CELLS AND T REGULATORY CELLS:

INFECTIOUS TOLERANCE MEDIATED BY DENDRITIC CELLS: A NOVEL MECHANISM OF ALLOGRAFT ACCEPTANCE THROUGH ACTIVATION OF T REGULATORY CELLS

Tolerogenic Dendritic Cells Transferring Hyporesponsiveness and Synergizing T Regulatory Cells in Transplant Tolerance

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance

IMMUNE MODULATION AND PREVENTION OF ALLOGENEIC GRAFT REJECTION BY THERAPEUTIC DENDRITIC CELLS:

Synergistic Tolerance Induced by LF15-0195 and Anti-Cd45rb Monoclonal Antibody Through Suppressive Dendritic Cells1

Adoptive Transfer of Dnt Cells Induces Long-Term Cardiac Allograft Survival and Augments Recipient Cd4(+)Foxp3(+) Treg Cell Accumulation

Adoptive Transfusion of Tolerance Dendritic Cells Prolongs the Survival of Cardiac Allograft: a Systematic Review of 44 Basic Studies in Mice

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Regulatory-B Cell and Regulatory-T Cell Collaborate to Promote Transplantation Tolerance (126.2)

Adoptive Transfusion of Tolerant Dendritic Cells Prolong the Survival of Renal Allografts: a Systematic Review

Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.

Transplant Tolerance Depends on Regulatory T Cells Induced by TGF-β-producing Regulatory B Cells (P2168)

Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.

DN-Treg Cells Induce Long-Term Cardiac Allograft Survival in Fully MHC Mismatched Recipients but Do Not Eliminate T Memory Cells (145.13)

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

Anti-ICAM-1 Antibody and CTLA-4Ig Synergistically Enhance Immature Dendritic Cells to Induce Donor-Specific Immune Tolerance in Vivo

Adoptive transfusion of tolerance dendritic cells prolongs the survival of skin allografts in mice: a systematic review.

Prevention of Allograft Rejection by in Vitro Generated Tolerogenic Dendritic Cells